Trial Profile
Bioequivalence Study of Lamivudine, Tenofovir Disoproxil Fumarate and Dolutegravir Tablets (300mg/300mg/50mg)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 Aug 2018
Price :
$35
*
At a glance
- Drugs Dolutegravir/lamivudine/tenofovir disoproxil fumarate (Primary) ; Dolutegravir; Lamivudine; Tenofovir dipivoxil fumarate
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 28 Aug 2018 New trial record
- 27 Jul 2018 Results presented at the 22nd International AIDS Conference